Article
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
The Journal of molecular diagnostics : JMD - 1 Mar 2018
Lindeman Neal I, Cagle Philip T, Aisner Dara L, Arcila Maria E, Beasley Mary Beth, Bernicker Eric H, Colasacco Carol, Dacic Sanja, Hirsch Fred R, Kerr Keith, Kwiatkowski David J, Ladanyi Marc, Nowak Jan A, Sholl Lynette, Temple-Smolkin Robyn, Solomon Benjamin, Souter Lesley H, Thunnissen Erik, Tsao Ming S, Ventura Christina B, Wynes Murry W, Yatabe Yasushi
Abstract excerpt
CONTEXT: In 2013, an evidence-based guideline was published by the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology to set standards for the molecular analysis of lung cancers to guide treatment decisions with targeted inhibitors. New evidence has prompted an evaluation of additional laboratory technologies, targetable genes,...
Topics
- Humans
- Adenocarcinoma
- Anaplastic Lymphoma Kinase
- Consensus
- ErbB Receptors
- Genetic Testing
- High-Throughput Nucleotide Sequencing